Anil Singarajipura
Overview
Explore the profile of Anil Singarajipura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shastri S, Sancheti P, Nagaraja S, Dayananda G, Srinivas P, Jayaprakash M, et al.
Lancet Reg Health Southeast Asia
. 2024 Mar;
22:100327.
PMID: 38482155
The WHO's "End TB" initiative aims to reduce catastrophic expenses, incidence, and mortality by 90%, 80%, and 0%, respectively by 2030 and Government of India has committed to reaching these...
2.
Nagarajan K, Kumarswamy K, Begum R, Panibatla V, Singarajipura A, Adepu R, et al.
Lancet Reg Health Southeast Asia
. 2024 Feb;
22:100372.
PMID: 38420270
Background: One-fifth of people with drug-resistance tuberculosis (DR-TB) who were initiated on newer shorter treatment regimen (with injection) had unfavourable treatment outcomes in India as on 2020. Evidence on self-driven...
3.
Potty R, Kumarasamy K, Munjattu J, Reddy R, Adepu R, Singarajipura A, et al.
Bull World Health Organ
. 2023 Jan;
101(1):28-35A.
PMID: 36593787
Objective: To assess treatment outcomes in tuberculosis patients participating in support group meetings in five districts of Karnataka and Telangana states in southern India. Methods: Tuberculosis patients from five selected...
4.
Shewade H, Nagaraja S, Vanitha B, Murthy H, Bhargava M, Singarajipura A, et al.
Glob Health Sci Pract
. 2022 Aug;
10(4).
PMID: 36041840
Due to the coronavirus disease (COVID-19) pandemic and its associated response, TB deaths increased for the first time in a decade. In any potentially fatal illness, an assessment of severity...
5.
Potty R, Kumarasamy K, Adepu R, Reddy R, Singarajipura A, Siddappa P, et al.
J Glob Health
. 2021 Jul;
11:04042.
PMID: 34326992
Background: Tuberculosis Health Action Learning Initiative (THALI) funded by USAID is a person-centered initiative, supporting vulnerable urban populations to gain access to TB services. THALI trained and placed 112 Community...
6.
Shewade H, Nagaraja S, Murthy H, Vanitha B, Bhargava M, Singarajipura A, et al.
Trop Med Infect Dis
. 2021 Jul;
6(2).
PMID: 34203984
Due to limited availability of diagnostics and capacity, people with tuberculosis do not always undergo systematic assessment for severe illness (requiring inpatient care). In Karnataka (south India), para-medical programme staff...
7.
Washington R, Potty R, Rajesham A, Seenappa T, Singarajipura A, Swamickan R, et al.
BMC Public Health
. 2020 Jul;
20(1):1158.
PMID: 32709228
Background: TB is a preventable and treatable disease. Yet, successful treatment outcomes at desired levels are elusive in many national TB programs, including India. We aim to identify risk factors...
8.
Naik P, Moonan P, Nirgude A, Shewade H, Satyanarayana S, Raghuveer P, et al.
Emerg Infect Dis
. 2018 Feb;
24(3):478-484.
PMID: 29460737
Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the...
9.
Akshaya K, Shewade H, Aslesh O, Nagaraja S, Nirgude A, Singarajipura A, et al.
Antimicrob Resist Infect Control
. 2017 Nov;
6:111.
PMID: 29142744
Background: Drug resistant tuberculosis (DR-TB) centers admit patients with DR-TB for initiation of treatment and thereby concentrate the patients under one setting. It becomes imperative to assess the compliance of...
10.
Kumar A, Singarajipura A, Naik B, Guddemane D, Patel Y, Shastri S, et al.
J Epidemiol Glob Health
. 2016 Jan;
7(1):11-19.
PMID: 26821235
For certain subgroups within people living with the human immunodeficiency virus (HIV) [active tuberculosis (TB), pregnant women, children <5years old, and serodiscordant couples], the World Health Organization recommends antiretroviral therapy...